Search

Your search keyword '"Yuan, Daijing"' showing total 15 results
Start Over Author "Yuan, Daijing"
15 results on '"Yuan, Daijing"'

5. Table S4 from Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials

Author

Shi, Donghua, primary, Shi, Yaoping, primary, Kaseb, Ahmed O., primary, Qi, Xingxing, primary, Zhang, Yuan, primary, Chi, Jiachang, primary, Lu, Qing, primary, Gao, Huiping, primary, Jiang, Hua, primary, Wang, Huamao, primary, Yuan, Daijing, primary, Ma, Hong, primary, Wang, Hongyang, primary, Li, Zonghai, primary, and Zhai, Bo, primary

Published
2023
Full Text
View/download PDF

6. Supplementary Methods from Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials

Author

Shi, Donghua, primary, Shi, Yaoping, primary, Kaseb, Ahmed O., primary, Qi, Xingxing, primary, Zhang, Yuan, primary, Chi, Jiachang, primary, Lu, Qing, primary, Gao, Huiping, primary, Jiang, Hua, primary, Wang, Huamao, primary, Yuan, Daijing, primary, Ma, Hong, primary, Wang, Hongyang, primary, Li, Zonghai, primary, and Zhai, Bo, primary

Published
2023
Full Text
View/download PDF

7. Protocol of Study 1 from Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials

Author

Shi, Donghua, primary, Shi, Yaoping, primary, Kaseb, Ahmed O., primary, Qi, Xingxing, primary, Zhang, Yuan, primary, Chi, Jiachang, primary, Lu, Qing, primary, Gao, Huiping, primary, Jiang, Hua, primary, Wang, Huamao, primary, Yuan, Daijing, primary, Ma, Hong, primary, Wang, Hongyang, primary, Li, Zonghai, primary, and Zhai, Bo, primary

Published
2023
Full Text
View/download PDF

8. Protocol of Study 2 from Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials

Author

Shi, Donghua, primary, Shi, Yaoping, primary, Kaseb, Ahmed O., primary, Qi, Xingxing, primary, Zhang, Yuan, primary, Chi, Jiachang, primary, Lu, Qing, primary, Gao, Huiping, primary, Jiang, Hua, primary, Wang, Huamao, primary, Yuan, Daijing, primary, Ma, Hong, primary, Wang, Hongyang, primary, Li, Zonghai, primary, and Zhai, Bo, primary

Published
2023
Full Text
View/download PDF

9. Phase Ⅱ Study of Fully Human BCMA-Targeting CAR-T Cells (Zevorcabtagene Autoleucel) in Patients with Relapsed/Refractory Multiple Myeloma

Author

Chen, Wenming, primary, Fu, Chengcheng, additional, Fang, Baijun, additional, Liang, Aibin, additional, Xia, Zhongjun, additional, He, Yanjuan, additional, Lu, Jin, additional, Liu, Hui, additional, Hou, Ming, additional, Cai, Zhen, additional, Yang, Wei, additional, Hao, Siguo, additional, Jiang, Songfu, additional, Jing, Hongmei, additional, Liu, Jing, additional, Du, Xin, additional, Fu, Rong, additional, Mei, Heng, additional, Zhu, Zunmin, additional, Yang, Yanli, additional, Liu, Hong, additional, Yuan, Daijing, additional, Zhao, Hongxia, additional, Xiao, Jun, additional, Wang, Wei, additional, Wang, Huamao, additional, and LI, Zonghai, additional

Published
2022
Full Text
View/download PDF

10. Safety, tolerability, and preliminary efficacy results in patients with advanced gastric/gastroesophageal junction adenocarcinoma from a phase Ib/II study of CLDN18.2 CAR T-cell therapy (CT041).

Author

QI, Changsong, primary, Liu, Chang, additional, Gong, Jifang, additional, Li, Jian, additional, Liu, Dan, additional, Ge, Sai, additional, Zhang, Miao, additional, Peng, Zhi, additional, Zhou, Jun, additional, Zhang, Xiaotian, additional, Zheng, Ji, additional, Xiao, Jun, additional, Yuan, Daijing, additional, Peng, Yueying, additional, Wang, Huamao, additional, Li, Zonghai, additional, and Shen, Lin, additional

Published
2022
Full Text
View/download PDF

11. Two-Year Follow-up of Investigator-Initiated Phase 1 Trials of the Safety and Efficacy of Fully Human Anti-Bcma CAR T Cells (CT053) in Relapsed/Refractory Multiple Myeloma

Author

Hao, Siguo, primary, Jin, Jie, additional, Jiang, Songfu, additional, Li, Zonghai, additional, Zhang, Wenhao, additional, Yang, Min, additional, Yu, Kang, additional, Wang, Wei, additional, Chen, Linjun, additional, Meng, Haitao, additional, He, Mingxia, additional, Xiao, Jun, additional, Tao, Rong, additional, Huang, Xin, additional, Xing, Chongyun, additional, Yuan, Daijing, additional, Wan, Jianbo, additional, Wang, Shasha, additional, Dai, Lihui, additional, and Ma, Hong, additional

Published
2020
Full Text
View/download PDF

12. Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials

Author

Shi, Donghua, primary, Shi, Yaoping, additional, Kaseb, Ahmed O., additional, Qi, Xingxing, additional, Zhang, Yuan, additional, Chi, Jiachang, additional, Lu, Qing, additional, Gao, Huiping, additional, Jiang, Hua, additional, Wang, Huamao, additional, Yuan, Daijing, additional, Ma, Hong, additional, Wang, Hongyang, additional, Li, Zonghai, additional, and Zhai, Bo, additional

Published
2020
Full Text
View/download PDF

13. Phase 1 Trial of the Safety and Efficacy of Fully Human Anti-Bcma CAR T Cells in Relapsed/Refractory Multiple Myeloma

Author

Jie, Jin, primary, Hao, Siguo, additional, Jiang, Songfu, additional, Li, Zonghai, additional, Yang, Min, additional, Zhang, Wenhao, additional, Yu, Kang, additional, Xiao, Jun, additional, Meng, Haitao, additional, Ma, Liyuan, additional, He, Mingxia, additional, WANG, Wei, additional, Huang, Xin, additional, Chen, Linjun, additional, Xing, Chongyun, additional, Yuan, Daijing, additional, Wang, Shasha, additional, Tao, Rong, additional, Dai, Lihui, additional, and Ma, Hong, additional

Published
2019
Full Text
View/download PDF

14. CT053, Anti-BCMA CAR T-cell therapy for Relapsed/Refractory Multiple Myeloma: Proof of Concept results from a Phase I Study

Author

Hao, Siguo, primary, Jin, Jie, additional, Yu, Kang, additional, Li, Zonghai, additional, Zhang, Wenhao, additional, Yang, Min, additional, Jiang, Songfu, additional, Chen, Peishuai, additional, Ma, Liyuan, additional, Meng, Haitao, additional, He, Mingxia, additional, Wang, Wei, additional, Chen, Linjun, additional, Huang, Xin, additional, Xing, Chongyun, additional, Yuan, Daijing, additional, Tao, Rong, additional, Wang, Shasha, additional, Dai, Lihui, additional, and Ma, Hong, additional

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results